22 May 2013
Keywords: strong, histology, data, b-ms, baraclude, drug, major
Article | 10 November 2008
US drug major Bristol-Myers Squibb says that data from two separate cohort evaluations show that long-term treatment with Baraclude
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
17 November 2008
21 May 2013
© 2013 thepharmaletter.com